Abstract The coronavirus disease 2019 (COVID‐19) pandemic has caused widespread
devastation, with millions of confirmed cases and deaths worldwide. Although there were …

The COVID-19 pandemic has had a devastating global impact, with older adults being most
at risk of death from the disease. However, acute sarcopenia occurs in survivors of COVID …

Coronavirus Disease (COVID-19) became a worldwide pandemic with a high hospitalisation
rate in March 2020. COVID-19 infection and sarcopenia concentrate on a same pathway that …

The tremendously rising numbers of aged populations are associated with a heightened risk
for motor and functional declines. Sarcopenia is an active age-related process that involves …

Abstract Coronavirus disease 2019 (COVID-19) spread rapidly and became a severe global
public health threat. Older adults have a high risk of COVID-19 and its associated mortality …

In this review, we discuss the pathophysiologic and management aspects of acute
sarcopenia in relation to SARS-CoV-2 infection. COVID-19 is as a multi-organ infectious …

The role of skeletal muscle mass in modulating immune response and supporting metabolic
stress has been increasingly confirmed. Patients with sarcopenia, characterized by reduced …

Background It has been speculated that patients with sarcopenia are aggravated by the
current novel coronavirus disease 2019 (COVID-19) epidemic. However, there is substantial …

Background Sarcopenia has been associated with patients' poor quality of life, disability,
and hospitalization. As of today, evidence that highlights the association between …

COVID-19 can manifest as either asymptomatic or progressing to a severe phase in some
patients, which may require hospitalization. These patients may experience dyspnea and …